A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Conditions: Breast Carcinoma; Breast Ductal Carcinoma in Situ Interventions: Behavioral: Patient Navigatrion; Other: Questionnaire Sponsors: Roswell Park Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Conditions: Ductal Carcinoma in Situ Interventions: Biological: MUC1 Peptide Vaccine; Drug: Hiltonol ®; Drug: Aromatase Inhibitor Sponsors: Finn, Olivera, PhD; A Glimmer of Hope Foundation; Breast Cancer Research Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS
Conditions: DCIS; Breast Carcinoma in Situ; Calcification Interventions: Diagnostic Test: Contrast Enhanced Mammography Sponsors: Clinical Hospital Center Rijeka Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Conditions: Breast Atypical Hyperplasia; Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ Interventions: Procedure: Biospecimen Collection; Procedure: Mammography; Drug: Omega-3-Acid Ethyl Esters; Other: Questionnaire Administration; Procedure: Random Periareolar Fine-Needle Aspiration; Drug: Tamoxifen Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Conditions: Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ; Estrogen Receptor-Positive Breast Carcinoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Mammography; Other: Questionnaire Administration; Drug: Tamoxifen Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
Conditions: Pancreatic Ductal Carcinoma Interventions: Drug: ProAgio Dose Levels (DL) 1,2,3,4; Drug: Gemcitabine, nab paclitaxel Sponsors: ProDa BioTech, LLC; University of Alabama at Birmingham; Georgia State University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study
ConclusionsRecruitment to LORIS was challenging despite strategies aimed at both patients and site staff. Ensuring that recruiting staff support the study could improve recruitment in similar future trials.Trial registrationISRCTN27544579, prospectively registered on 22 May 2014 (Source: Trials)
Source: Trials - October 14, 2023 Category: Research Source Type: clinical trials
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Conditions: Ductal Carcinoma in Situ Interventions: Drug: Tamoxifen; Drug: Exemestane; Drug: Letrozole; Drug: Anastrazole; Drug: T+Ai; Drug: Elacestrant Sponsors: QuantumLeap Healthcare Collaborative Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Oncotype DX DCIS: Impact on Radiotherapy Decision Making
Condition: Breast Cancer Intervention: Diagnostic Test: ONCOTYPE DX DCIS test Sponsor: Royal Marsden NHS Foundation Trust Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
